Status: Recruiting
Tissue Repair Gel in Venous Leg Ulcers (US)
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Participants needed: 312
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: TR TherapeuticsUpdated: Feb 12, 2026Locations: 33
Eligibility criteria
Adults 18 years and older [+7]
Target ulcer has been treated with prohibited medications or therapies. [+4]